Survival analysis revealed that low NR4A1 expression is associated with poor cancer-specific survival in DLBCL9, which could be confirmed in an independent cohort of the publicly available gene expression dataset of Lenz et al. 10. This evidence concerns the gene NR4A1 and cancer.